Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain
- 1 February 2014
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 22 (3) , 1208-1217
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institute of Health and the Department of Health and Human Services (AI080671)
- Spanish Ministry of Science and Innovation
This publication has 35 references indexed in Scilit:
- Novel Application of Human Neurons Derived from Induced Pluripotent Stem Cells for Highly Sensitive Botulinum Neurotoxin DetectionToxicological Sciences, 2012
- Carbamate Prodrug Concept for Hydroxamate HDAC InhibitorsChemMedChem, 2011
- Chirality Holds the Key for Potent Inhibition of the Botulinum Neurotoxin Serotype A ProteaseOrganic Letters, 2010
- A Potent Peptidomimetic Inhibitor of Botulinum Neurotoxin Serotype A Has a Very Different Conformation than SNAP-25 SubstrateStructure, 2008
- Toward the discovery of potent inhibitors of botulinum neurotoxin A: development of a robust LC MS based assay operational from low to subnanomolar enzyme concentrationsChemical Communications, 2008
- A neuronal cell‐based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodiesFEBS Letters, 2007
- An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonistsProceedings of the National Academy of Sciences, 2007
- Synthesis, Characterization and Development of a High-Throughput Methodology for the Discovery of Botulinum Neurotoxin A InhibitorsJournal of Combinatorial Chemistry, 2006
- Identification of a Potent Botulinum Neurotoxin A Protease Inhibitor Using in Situ Lead Identification ChemistryOrganic Letters, 2006
- Cut-off QFT and black hole entropyJournal of High Energy Physics, 2003